{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:15:53Z","timestamp":1788984953000,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No.2026NSFSC0576"],"award-info":[{"award-number":["No.2026NSFSC0576"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jhep.2026.06.028","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:50:47Z","timestamp":1783090247000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Moving too fast? A meta-analysis calls for caution on TNF inhibitors as first-line therapy for autoimmune hepatitis"],"prefix":"10.1016","author":[{"given":"Wenhui","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taolei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8434-2969","authenticated-orcid":false,"given":"Xiaoli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.06.028_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jhep.2026.02.026","article-title":"Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis","volume":"85","author":"Xu","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.06.028_bib2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2026.06.028_bib3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jhep.2026.06.028_bib4","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/HEP.0000000000001089","article-title":"Efficacy and safety of infliximab in patients with autoimmune hepatitis","volume":"81","author":"Efe","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.06.028_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.06.028_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(17)31057-7","article-title":"TNF\u03b1 as therapeutic target in Autoimmune Hepatitis","volume":"66","author":"Bovensiepen","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.06.028_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL Clinical Practice Guidelines on the management of autoimmune hepatitis","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.06.028_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-022-00937-5","article-title":"B cells in autoimmune hepatitis: bystanders or central players?","volume":"44","author":"Schulthei\u00df","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jhep.2026.06.028_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jhep.2026.06.028_bib10","article-title":"Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis","volume":"7","author":"D\u00edaz-Gonz\u00e1lez","year":"2025","journal-title":"JHEP Rep"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826026619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826026619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:41:32Z","timestamp":1788982892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826026619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":10,"alternative-id":["S0168827826026619"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.06.028","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving too fast? A meta-analysis calls for caution on TNF inhibitors as first-line therapy for autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.02.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}